- Establishes a unified, evidence-based global definition and diagnostic framework for ACLF to harmonise clinical practice, research, and education.
- Integrates regional definitions and international perspectives to create a pragmatic, globally applicable foundation for patient management and stratification.
- Defines standardised, regulatory-aligned endpoints and frameworks for organ dysfunction, critical care, transplantation, and phase II/III trial design to accelerate therapies.
Ann Hepatol. 2026 Oct 30:102453. doi: 10.1016/j.aohep.2026.102453. Online ahead of print.
ABSTRACT
The acute-on-chronic liver failure (ACLF) multisociety harmonisation initiative represents a global collaborative effort to establish a unified, evidence-based framework for the definition, diagnosis, grading, and management of ACLF. Building on the strengths of existing regional definitions and integrating diverse international perspectives, this consensus provides a pragmatic, globally applicable foundation for clinical practice, research, and education. It also establishes a common framework for patient stratification, organ dysfunction and failure assessment, critical care management, liver transplantation, and the design of future phase II/III trials. Standardised, regulatory-aligned endpoints are expected to improve cross-study comparability, strengthen collaboration, and accelerate development of effective ACLF therapies.
PMID:42962711 | DOI:10.1016/j.aohep.2026.102453
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

